Influence of different degrees of liver impairment on the pharmacokinetics of clazosentan

Lignende værker

• Influence of mild liver impairment on the pharmacokinetics of tezosentan, a drug excreted unchanged into bile
  af: Dingemanse, Jasper, et al.
  Udgivet: (2004)
• Influence of Rifampin‐Mediated Organic Anion‐Transporting Polypeptide 1B1/1B3 Inhibition on the Pharmacokinetics of Clazosentan
  af: Juif, Pierre‐Eric, et al.
  Udgivet: (2019)
• Pharmacokinetics of the novel oral prostacyclin receptor agonist selexipag in subjects with hepatic or renal impairment
  af: Kaufmann, Priska, et al.
  Udgivet: (2016)
• Pharmacokinetics of intravenous telavancin in healthy subjects with varying degrees of renal impairment
  af: Worboys, Philip D., et al.
  Udgivet: (2015)
• Effect of gemfibrozil and rifampicin on the pharmacokinetics of selexipag and its active metabolite in healthy subjects
  af: Bruderer, Shirin, et al.
  Udgivet: (2017)